NUTANIX ($NTNX) posted quarterly earnings results for Q2 2026 on Wednesday, February 25th. The company reported earnings of $0.56 per share, beating estimates of $0.46 by $0.10. The company also reported revenue of $722,830,000, missing estimates of $724,146,409 by $-1,316,409.
Stock price change since market close: +15.3%
You can see Quiver Quantitative's $NTNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NUTANIX Insider Trading Activity
NUTANIX insiders have traded $NTNX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $NTNX stock by insiders over the last 6 months:
- RAJIV RAMASWAMI (President and CEO) has made 0 purchases and 2 sales selling 144,707 shares for an estimated $11,059,200.
- RUKMINI SIVARAMAN (Chief Financial Officer) sold 11,391 shares for an estimated $892,414
- BRIAN MARTIN (Chief Legal Officer) sold 10,241 shares for an estimated $783,731
- TERESA GAYLE SHEPPARD has made 0 purchases and 2 sales selling 3,500 shares for an estimated $267,691.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NUTANIX Hedge Fund Activity
We have seen 244 institutional investors add shares of NUTANIX stock to their portfolio, and 459 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 5,822,793 shares (-80.0%) from their portfolio in Q4 2025, for an estimated $300,980,170
- AQR CAPITAL MANAGEMENT LLC added 4,826,443 shares (+72.8%) to their portfolio in Q4 2025, for an estimated $249,478,838
- GENERATION INVESTMENT MANAGEMENT LLP removed 3,013,651 shares (-46.8%) from their portfolio in Q4 2025, for an estimated $155,775,620
- FIL LTD added 2,786,929 shares (+180.1%) to their portfolio in Q4 2025, for an estimated $144,056,360
- CITADEL ADVISORS LLC added 2,430,339 shares (+9636.9%) to their portfolio in Q4 2025, for an estimated $125,624,222
- ALYESKA INVESTMENT GROUP, L.P. added 2,425,665 shares (+926.8%) to their portfolio in Q4 2025, for an estimated $125,382,623
- FEDERATED HERMES, INC. removed 2,210,012 shares (-62.1%) from their portfolio in Q4 2025, for an estimated $114,235,520
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NUTANIX Analyst Ratings
Wall Street analysts have issued reports on $NTNX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/05/2026
- Goldman Sachs issued a "Buy" rating on 11/28/2025
- JP Morgan issued a "Overweight" rating on 11/26/2025
- Needham issued a "Buy" rating on 11/26/2025
- Piper Sandler issued a "Overweight" rating on 11/26/2025
- Keybanc issued a "Overweight" rating on 11/26/2025
- B of A Securities issued a "Buy" rating on 11/26/2025
To track analyst ratings and price targets for NUTANIX, check out Quiver Quantitative's $NTNX forecast page.
NUTANIX Price Targets
Multiple analysts have issued price targets for $NTNX recently. We have seen 12 analysts offer price targets for $NTNX in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Meta Marshall from Morgan Stanley set a target price of $56.0 on 02/24/2026
- Matthew Martino from Goldman Sachs set a target price of $60.0 on 02/09/2026
- Tim Long from Barclays set a target price of $53.0 on 01/15/2026
- Matthew Hedberg from RBC Capital set a target price of $65.0 on 01/05/2026
- James Fish from Piper Sandler set a target price of $72.0 on 11/26/2025
- Brandon Nispel from Keybanc set a target price of $65.0 on 11/26/2025
- Aaron Rakers from Wells Fargo set a target price of $57.0 on 11/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
